KR950700290A - 피페라진 및 피레리딘 유도체, 및 이들의 항정신병제로서의 용도(piperazine and piperidine derivatives, and their use as antipsychotics) - Google Patents

피페라진 및 피레리딘 유도체, 및 이들의 항정신병제로서의 용도(piperazine and piperidine derivatives, and their use as antipsychotics)

Info

Publication number
KR950700290A
KR950700290A KR1019940702790A KR19940702790A KR950700290A KR 950700290 A KR950700290 A KR 950700290A KR 1019940702790 A KR1019940702790 A KR 1019940702790A KR 19940702790 A KR19940702790 A KR 19940702790A KR 950700290 A KR950700290 A KR 950700290A
Authority
KR
South Korea
Prior art keywords
antipsychotics
piperazine
derivatives
piperidine
pyridine
Prior art date
Application number
KR1019940702790A
Other languages
English (en)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of KR950700290A publication Critical patent/KR950700290A/ko

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D275/00Heterocyclic compounds containing 1,2-thiazole or hydrogenated 1,2-thiazole rings
    • C07D275/04Heterocyclic compounds containing 1,2-thiazole or hydrogenated 1,2-thiazole rings condensed with carbocyclic rings or ring systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/04Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/14Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Plural Heterocyclic Compounds (AREA)
KR1019940702790A 1992-02-12 1994-08-12 피페라진 및 피레리딘 유도체, 및 이들의 항정신병제로서의 용도(piperazine and piperidine derivatives, and their use as antipsychotics) KR950700290A (ko)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB929202915A GB9202915D0 (en) 1992-02-12 1992-02-12 Chemical compounds
PCT/GB1993/000285 WO1993016073A1 (en) 1992-02-12 1993-02-11 Piperazine and piperidine derivatives, and their use as antipsychotics

Publications (1)

Publication Number Publication Date
KR950700290A true KR950700290A (ko) 1995-01-16

Family

ID=10710223

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1019940702790A KR950700290A (ko) 1992-02-12 1994-08-12 피페라진 및 피레리딘 유도체, 및 이들의 항정신병제로서의 용도(piperazine and piperidine derivatives, and their use as antipsychotics)

Country Status (16)

Country Link
EP (1) EP0625978A1 (ko)
JP (1) JPH07503723A (ko)
KR (1) KR950700290A (ko)
AU (1) AU3460393A (ko)
CA (1) CA2117434A1 (ko)
CZ (1) CZ194994A3 (ko)
FI (1) FI943718A0 (ko)
GB (1) GB9202915D0 (ko)
HU (1) HUT72309A (ko)
IL (1) IL104690A0 (ko)
MX (1) MX9300786A (ko)
NO (1) NO942977L (ko)
RU (1) RU94038064A (ko)
SK (1) SK96494A3 (ko)
WO (1) WO1993016073A1 (ko)
ZA (1) ZA93958B (ko)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5776963A (en) * 1989-05-19 1998-07-07 Hoechst Marion Roussel, Inc. 3-(heteroaryl)-1- (2,3-dihydro-1h-isoindol-2-yl)alkyl!pyrrolidines and 3-(heteroaryl)-1- (2,3-dihydro-1h-indol-1-yl)alkyl!pyrrolidines and related compounds and their therapeutic untility
US5364866A (en) 1989-05-19 1994-11-15 Hoechst-Roussel Pharmaceuticals, Inc. Heteroarylpiperidines, pyrrolidines and piperazines and their use as antipsychotics and analetics
RU2118322C1 (ru) * 1993-07-05 1998-08-27 Дюфар Интернэшнл Рисерч Б.В. 2,3-дигидро-1,4-бензодиокси-5-ил-пиперазиновые производные или их соли
CN1058492C (zh) * 1993-12-24 2000-11-15 三得利株式会社 苯并噻嗪衍生物
JPH0912562A (ja) * 1995-06-22 1997-01-14 Suntory Ltd 置換ベンゾチアジン誘導体
US5874429A (en) * 1993-12-24 1999-02-23 Suntory Limited Benzothiazine derivative
US6001827A (en) 1993-12-24 1999-12-14 Suntory Limited Benzothiazine derivative
JP3948744B2 (ja) * 1994-11-04 2007-07-25 大日本住友製薬株式会社 新規なラクタム誘導体
EP0732332B1 (en) * 1995-03-17 2001-12-19 Aventis Pharmaceuticals Inc. Substituted benzothienylpiperazines, their use as medicaments, and processes for their preparation
US6087364A (en) * 1998-01-29 2000-07-11 Warner-Lambert Company Dopamine D4 receptor antagonists
DE19814084B4 (de) 1998-03-30 2005-12-22 Lts Lohmann Therapie-Systeme Ag D2-Agonist enthaltendes transdermales therapeutisches System zur Behandlung des Parkinson-Syndroms und Verfahren zu seiner Herstellung
US7030142B1 (en) 1999-04-06 2006-04-18 Sepracor Inc. Methods for the treatment of neuroleptic and related disorders using ziprasidone metabolites
EP1165083A2 (en) * 1999-04-06 2002-01-02 Sepracor Inc. Methods and compositions for the treatment of psychotic and related disorders using ziprasidone metabolites
AR028685A1 (es) 2000-06-14 2003-05-21 Lundbeck & Co As H Derivados de indol
US8246979B2 (en) 2002-07-30 2012-08-21 Ucb Pharma Gmbh Transdermal delivery system for the administration of rotigotine
US8246980B2 (en) 2002-07-30 2012-08-21 Ucb Pharma Gmbh Transdermal delivery system
DE10234673B4 (de) 2002-07-30 2007-08-16 Schwarz Pharma Ag Heißschmelz-TTS zur Verabreichung von Rotigotin und Verfahren zu seiner Herstellung sowie Verwendung von Rotigotin bei der Herstellung eines TTS im Heißschmelzverfahren
DE60327634D1 (de) 2002-08-22 2009-06-25 Dainippon Sumitomo Pharma Co Mittel zur behandlung des integrationsdysfunktionssyndroms
DE10261696A1 (de) 2002-12-30 2004-07-15 Schwarz Pharma Ag Vorrichtung zur transdermalen Verabreichung von Rotigotin-Base
EP1637530A4 (en) * 2003-06-23 2009-04-01 Dainippon Sumitomo Pharma Co THERAPEUTIC AGENT FOR SENILE DEMENTIA
DE10334188B4 (de) 2003-07-26 2007-07-05 Schwarz Pharma Ag Verwendung von Rotigotin zur Behandlung von Depressionen
JP4847320B2 (ja) 2004-02-20 2011-12-28 大日本住友製薬株式会社 統合失調症の記憶・学習機能障害治療薬のinvivoスクリーニング方法
EA200900937A1 (ru) * 2007-01-03 2009-12-30 Кортекс Фармасеутикалс, Инк. Соединения 3-замещенного-[1,2,3]бензотриазинона для усиления глутаматергических синаптических ответов
US8258139B2 (en) 2010-11-08 2012-09-04 Dainippon Sumitomo Pharma Co., Ltd. Method of treatment for mental disorders
GB201102248D0 (en) 2011-02-09 2011-03-23 Isis Innovation Treatment of bipolar disorder
WO2013014665A1 (en) * 2011-07-28 2013-01-31 Mapi Pharma Ltd. Intermediate compounds and process for the preparation of lurasidone and salts thereof
US9901577B2 (en) * 2013-07-31 2018-02-27 Merck Patent Gmbh Oxoquinazolinyl-butanamide derivatives
CN105669665A (zh) * 2016-03-15 2016-06-15 烟台贝森医药科技有限公司 哌罗匹隆的制备方法
US11246905B2 (en) 2016-08-15 2022-02-15 President And Fellows Of Harvard College Treating infections using IdsD from Proteus mirabilis
CN115124464B (zh) * 2022-07-04 2023-06-06 新乡学院 一种喹啉二酮磺酰哌嗪杂合体及其制备方法和应用

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2258843B1 (ko) * 1974-01-30 1977-09-09 Roussel Uclaf
US4335127A (en) * 1979-01-08 1982-06-15 Janssen Pharmaceutica, N.V. Piperidinylalkyl quinazoline compounds, composition and method of use
JPH0625181B2 (ja) * 1985-03-27 1994-04-06 住友製薬株式会社 新規なイミド誘導体
AU593194B2 (en) * 1986-09-26 1990-02-01 Sumitomo Pharmaceuticals Company, Limited Imide derivatives ,and their production and use
CA1335289C (en) * 1987-10-26 1995-04-18 Fujio Antoku Piperidinyl benzisoxazole derivatives, their production and pharmaceutical use
US5001130A (en) * 1988-02-18 1991-03-19 Bristol-Myers Company Psychotropic heterobicycloalkylpiperazine derivatives
US4780466A (en) * 1988-03-17 1988-10-25 Hoechst-Roussel Pharmaceuticals, Inc. Arylpiperazinylalkoxy derivatives of cyclic imides
NZ230045A (en) * 1988-08-05 1990-11-27 Janssen Pharmaceutica Nv 3-piperazinylbenzazole derivatives and pharmaceutical compositions
US4968792A (en) * 1989-09-25 1990-11-06 American Home Products Corporation Psychotropic benzisothiazole derivatives
JP2800953B2 (ja) * 1990-07-06 1998-09-21 住友製薬株式会社 新規なイミド誘導体

Also Published As

Publication number Publication date
FI943718A (fi) 1994-08-11
CA2117434A1 (en) 1993-08-19
JPH07503723A (ja) 1995-04-20
FI943718A0 (fi) 1994-08-11
NO942977D0 (no) 1994-08-11
CZ194994A3 (en) 1995-09-13
MX9300786A (es) 1994-03-31
HU9402343D0 (en) 1994-10-28
GB9202915D0 (en) 1992-03-25
ZA93958B (en) 1994-08-11
IL104690A0 (en) 1993-06-10
WO1993016073A1 (en) 1993-08-19
AU3460393A (en) 1993-09-03
HUT72309A (en) 1996-04-29
RU94038064A (ru) 1997-05-27
NO942977L (no) 1994-10-10
EP0625978A1 (en) 1994-11-30
SK96494A3 (en) 1995-07-11

Similar Documents

Publication Publication Date Title
KR950700290A (ko) 피페라진 및 피레리딘 유도체, 및 이들의 항정신병제로서의 용도(piperazine and piperidine derivatives, and their use as antipsychotics)
NO932176D0 (no) Kinolin-, naftyridin- og pyridobenzoksazinderivater
DE69019550D1 (de) Piperidin-Derivate, ihre Herstellung und ihre Verwendung.
NL350021I2 (nl) 3-Aryl-4-hydroxy-delta-3-dihydrofuranonen en 3-aryl-4-hydroxy-delta-3-dihydrothiofenon-derivaten.
DE3875159D1 (de) Piperidylaminotriazin-derivate und ihre anwendung als stabilisatoren.
FI955164A0 (fi) Heterosykliset johdannaiset
DK451588D0 (da) Heterocycliske forbindelser, deres fremstilling og laegemidler indeholdende forbindelserne
ITMI922661A0 (it) Derivati eterociclici
DE69216260D1 (de) Piperidinderivate
BR9606815A (pt) Derivados de piperidina 4-(1H-indolil-1-il)-1-substituídos antipsicóticos
FI955679A0 (fi) Piperidiinijohdannaisia, niiden valmistus ja käyttö
DK101689D0 (da) 4-substituerede pyrazolooe3,4-daapyrimidinderivater
DK91890D0 (da) Piperazin-derivater
DE3876846D1 (de) Morpholinderivate und deren verwendung.
FI961977A0 (fi) N-substituoidut atsabisykloalkaanijohdannaiset, niiden valmistus ja käyttö
EP0272589A3 (en) Polyalkyl piperidine derivatives with alkylene bridges, their use as stabilizers and intermidiates
DE69203699D1 (de) Arylindazolderivate und ihre Verwendung.
NO903229D0 (no) Substituerte isoksazol- og isotiazolderivater.
DE3889336D1 (de) Alkyltetramethylcyclohexan-derivate und deren verwendung als duftstoffe.
FI950303A0 (fi) Pyridoindolobentsodiatsepiinit ja johdannaiset antipsykoottisina aineina
DE69123168D1 (de) Piperidinderivate und diese enthaltende Antiulcer-Präparate
FI963353A (fi) Piperidiinijohdannaiset, menetelmä niiden valmistamiseksi sekä niiden käyttö
NO923042D0 (no) 4,5-cykloalkano-3-benzazepin-7-ol-derivater og deres anvendelse
ATE104945T1 (de) Alkyltetramethylcyclohexan-derivate und deren verwendung als duftstoffe.
ATE104289T1 (de) Aminoethylthiazole und aminoethyloxazol-derivate.

Legal Events

Date Code Title Description
WITN Application deemed withdrawn, e.g. because no request for examination was filed or no examination fee was paid